PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus
Clinical trial NCT01162681 · COMPLETED
Trial details
- NCT number
- NCT01162681
- Sponsor
- Anthera Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2012-04-01
- Enrollment
- 547
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.